The treatment of cardiovascular risk in primary care using electronic decision support (TORPEDO) study: Intervention development and protocol for a cluster randomised, controlled trial of an electronic decision support and quality improvement intervention in Australian primary healthcare

BMJ Open

Volumn 2, Issue 6, 2012, Pages

  Peiris, David ^a   Usherwood, Tim ^b   Panaretto, Katie ^c   Harris, Mark ^d   Hunt, Jenny ^e   Patel, Bindu ^a   Zwar, Nicholas ^d   Redfern, Julie ^a   MacMahon, Stephen ^a   Colagiuri, Stephen ^b   Hayman, Noel ^f   Patel, Anushka ^a  

^a GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Queensland Aboriginal and Islander Health Council   (Australia)

^d UNIVERSITY OF NEW SOUTH WALES   (Australia)

^e Australia   (Australia)

^f Inala Indigenous Health Service   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; CARDIOVASCULAR RISK; DECISION SUPPORT SYSTEM; ELECTRONIC DECISION SUPPORT SYSTEM; HEALTH CARE QUALITY; HEALTH SERVICE; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE;

EID: 84871103369     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-002177     Document Type: Article

References (40)

1. Australian Institute of Health and Welfare. Australia's Health 2012. Australia's health series no.13. Cat. no. AUS 156. Canberra: AIHW, 2012.
2. Vos T, Barker B, Stanley L, et al. The burden of disease and injury in Aboriginal and Torres Strait Islander peoples 2003. Brisbane: University of Queensland, 2007.
3. Australian Institute of Health and Welfare. Australia's Health 2008. Cat. no. 99. Canberra: AIHW, 2008.
4. Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002;324:71-86.
5. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22.
6. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001;358:1033-41.
7. Simes J, Furberg CD, Braunwald E, et al. Effects of pravastatin on mortality in patients with and without coronary heart disease across a broad range of cholesterol levels. Eur Heart J 1997;23:207-15.
8. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. New Engl J Med 2000;342:145-53.
9. Heeley E, Peiris D, Patel A, et al. Cardiovascular risk perception and the evidence practice gap in Australian General Practice (the AusHEART study). Med J Aust 2010;192:254-9.
10. Peiris D, Patel A, Cass A, et al. Cardiovascular disease risk management for Aboriginal and Torres Strait Islander peoples in primary health care settings - findings from the Kanyini Audit. Med J Aust 2009;191:304-9.
11. Webster R, Heeley E, Peiris D, et al. Identifying the gaps in cardiovascular risk management. Med J Aust 2009;191:324-9.
12. Reid C, Nelson MR, Shiel L, et al. Australians at risk: management of cardiovascular risk factors in the REACH Registry. Heart Lung Circ 2008;17:114-18. (Pubitemid 351377555)
13. Wan Q, Harris MF, Jayasinghe UW, et al. Quality of diabetes care and coronary heart disease absolute risk in patients with type 2 diabetes mellitus in Australian general practice. Qual Saf Health Care 2006;15:131-5.
14. Steven I, Wing L. Control and cardiovascular risk factors of hypertension. An assessment of a sample of patients. Aust Fam Physician 1999;28:45-8.
15. Vale MJ, Jelinek MV, Best JD. How many patients with coronary heart disease are not achieving their risk-factor targets? Experience in Victoria 1996-1998 versus 1999-2000. Med J Aust 2002;176:211-15. (Pubitemid 34201929)
16. Diabetes Trials Unit - The Oxford Centre for Diabetes Endocrinology and Metabolism. UKPDS Risk Engine . 2009. http://www.dtu.ox.ac.uk/index.php?maindoc= /riskengine/ (accessed 2 Oct 2012).
17. National Vascular Disease Prevention Alliance. Guidelines for the assessment of absolute cardiovascular disease risk. 2009. http://www. heartfoundation.org.au/SiteCollectionDocuments/ guidelines-Absolute-risk.pdf (accessed 21 Sep 2012).
18. Hippisley-Cox J, Coupland C, Vinogradova Y, et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008;336:1475-82. (Pubitemid 351977019)
19. National Heart Lung and Blood Institute. Framingham Heart Study. 2009.http://www.framinghamheartstudy.org/about/index.html (accessed 2 Oct 2012).
20. New Zealand Guidelines Group. New Zealand Cardiovascular Guidelines Handbook: a summary resource for primary care practitioners. 2nd edn. Wellington: New Zealand Guidelines Group, 2009.
21. Woodward M, Brindle P, Tunstall-Pedoe H. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007;93:172-6. (Pubitemid 46180289)
22. Peiris D, Joshi R, Webster R, et al. An electronic clinical decision support tool to assist primary care providers in cardiovascular disease risk management: development and mixed methods evaluation. J Med Internet Res 2009;11:e51.
23. Torley D, Zwar N, Comino EJ, et al. GPs' views of absolute cardiovascular risk and its role in primary prevention. Aust Fam Physician 2005;34:503-4.
24. National Vascular Disease Prevention Alliance. Guidelines for the management of absolute cardiovascular disease risk. 2012. http:// strokefoundation.com.au/health-professionals/clinical-guidelines/ guidelines-for-the-assessment-and-management-of-absolute-cvdrisk/ (accessed 18 Sep 2012).
25. Wan Q, Harris MF, Zwar N, et al. Prerequisites for implementing cardiovascular absolute risk assessment in general practice: a qualitative study of Australian GPs' and patients ' views. J Eval Clin Pract 2010;16:580-4.
26. Garg AX, Adhikari NK, McDonald H, et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes a systematic review. JAMA 2005;293:1223-38. (Pubitemid 40327908)
27. Shojania KG, Jennings A, Mayhew A, et al. The effects of onscreen, point of care computer reminders on processes and outcomes of care. Cochrane Database Syst Rev 2009;CD001096.
28. Kawamoto K, Houlihan CA, Balas AE, et al. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ 2005;330:765.
29. Shea S, DeMouchel W, Bahamonde LA. Meta-analysis of 16 randomized controlled trials to evaluate computer-based clinical reminder systems for preventive care in the ambulatory setting. J Am Med Inform Assoc 1996;3:399-409. (Pubitemid 126445041)
30. Bright TJ, Wong A, Dhurjati R, et al. Effect of clinical decision-support systemsa systematic review. Ann Intern Med 2012;157:29-43.
31. Eccles M, McColl E, Steen N, et al. Effect of computerised evidence based guidelines on management of asthma and angina in adults in primary care: cluster randomised controlled trial. BMJ 2002;325:941.
32. Hetlevik IHJ, Krüger O, Kristensen P, Iversen H, Furuseth K. Implementing clinical guidelines in the treatment of diabetes mellitus in general practice. Evaluation of effort, process, and patient outcome related to implementation of a computer-based decision support system. Int J Technol Assess Health Care 2000;16:210-27. (Pubitemid 30263215)
33. Hetlevik IHJ, Krüger O, Kristensen P, Iversen H, Furuseth K. Implementing clinical guidelines in the treatment of hypertension in general practice. Evaluation of patient outcome related to implementation of a computer-based clinical decision support system. Scand J Prim Health Care 2000;17:35-40.
34. Meigs JB, Cagliero E, Dubey A, et al. A controlled trial of web-based diabetes disease management. Diabetes Care 2003;26:750-7.
35. Montgomery AA, Fahey T, Peters TJ, et al. Evaluation of computer based clinical decision support system and risk chart for management of hypertension in primary care: randomised controlled trial. BMJ 2000;320:686-90. (Pubitemid 30179394)
36. Wells S, Furness S, Rafter N, et al. Integrated electronic decision support increases cardiovascular disease risk assessment four fold in routine primary care practice. Eur J Cardiovasc Prev Rehabil 2008;15:173-8. (Pubitemid 351507649)
37. Anderson KM, Wilson PW, Odell PM, et al. An updated coronary risk profile. A statement for health professionals. Circulation 1991;83:356-62.
38. Donner A, Klar N. Design and analysis of cluster randomization trials in health research. London: Arnold, 2000.
39. Patton M. Qualitative research and evaluation methods. Thousand Oaks, CA: Sage, 2002.
40. Greatbatch D, Murphy E, Dingwall R. Evaluating medical information systems: ethnomethodological and interactionist approaches. Health Serv Manage Res 2001;14:181-91. (Pubitemid 32725088)